We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters |

Diagnosis of Pertussis—Reply

Ralph Gonzales, MD, MSPH; Paul B. Cornia, MD; Tom Newman, MD, MPH
JAMA. 2010;304(21):2358-2359. doi:10.1001/jama.2010.1726.
Text Size: A A A
Published online


In Reply: In response to Dr Linder, the difference in pretest probabilities for pertussis infection between those in studies we cited and those from the Acellular Pertussis Vaccine Trial (APERT)1 is probably due to differences in the study populations. The community-based studies we cited reflect the prevalence of pertussis infection among patients who sought care for persistent cough illness. In contrast, the APERT trial included cough illnesses that were reported by participants in response to bimonthly telephone calls from the study staff. It seems likely that the threshold for telephone reporting of persistent cough might be lower than the threshold for seeking medical care for the cough. Such a low threshold is supported by the large number of participants from both treatment and control groups who reported a cough illness lasting more than 3 weeks during the 2.5 years of the APERT study (1047/2781 [38%]). For the purpose of estimating the baseline probability of pertussis infection in a clinical care setting, we believe the estimate from a study population of patients who seek care is most appropriate. Importantly, the true prevalence of pertussis infection is difficult to determine because of the pathobiology of the infection and the limitations of available diagnostic tests.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




December 1, 2010
Jeffrey A. Linder, MD, MPH
JAMA. 2010;304(21):2358-2359. doi:10.1001/jama.2010.1725.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.